FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to using probiotics in the manufacture of a drug or a therapeutic nutritional composition for long-term prevention of diarrhea in infants. Using the probiotic Lactobacillus rhamnosus ATCC 53103 or Lactobacillus rhamnosus CGMCC 1.3724, and the probiotic Bifidobacterium longum ATCC BAA-999 in the manufacture of a drug or a therapeutic nutritional composition to be introduced into an infant for at least three months for the purpose of long-term prevention of diarrhoea, wherein the probiotic is introduced into a breastfeeding infant from a nursing mother.
EFFECT: using the above probiotic strains from the nursing mother is effective for the purpose of long-term prevention of diarrhoea in infants.
6 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PROBIOTICS FOR REDUCING RISK OF OBESITY | 2008 |
|
RU2464994C2 |
BABY MIXTURE CONTAINING PROBIOTICS | 2006 |
|
RU2428886C2 |
NOURISHING COMPOSITION, INCLUDING PROBIOTICS AND IMPROVING SLEEP PATTERN | 2009 |
|
RU2517616C2 |
USING STRAIN Bifidobacterium lactis CNCM I-3446 IN CHILDREN DELIVERED BY CESAREAN SECTION (VERSIONS) AND PROBIOTIC COMPOSITION CONTAINING ABOVE STRAIN (VERSIONS) | 2008 |
|
RU2521500C2 |
NUTRITIONAL COMPOSITIONS CONTAINING LACTOFERRIN AND PROBIOTICS AND SETS OF THEIR PARTS | 2010 |
|
RU2543815C2 |
PROBIOTIC BACTERIAL STRAIN FOR OBTAINING NUTRIENT COMPOSITION IMPROVING SLEEP NATURE | 2009 |
|
RU2642301C9 |
PROBIOTICS FOR IMPROVING TgA SECRETION IN INFANTS BORN BY CAESAREAN SECTION | 2009 |
|
RU2496505C2 |
SYNBIOTIC MIXTURE | 2007 |
|
RU2448720C2 |
SET OF PROBIOTIC-CONTAINING NUTRITIONAL MIXTURES CREATED WITH ACCOUNT FOR AGE | 2011 |
|
RU2570473C2 |
INFANT FORMULA WITH PROBIOTICS AND MILK FAT GLOBULE MEMBRANE COMPONENTS | 2010 |
|
RU2563355C2 |
Authors
Dates
2013-08-27—Published
2008-02-20—Filed